Ruben Mesa, MD: Ruxolitinib as a Myelofibrosis Treatment

Press/Media: Press / Media

PeriodJun 7 2019

Media coverage

1

Media coverage

  • TitleRuben Mesa, MD: Ruxolitinib as a Myelofibrosis Treatment
    Media name/outletHCPLive
    CountryUnited States
    Date6/7/19
    PersonsRuben Mesa